Day One Biopharmaceuticals Newsroom

J.P. Morgan Maintains Day One Biopharmaceuticals(DAWN.US) With Buy Rating

Moomoo NewsNov 4 08:31 ET

Day One Biopharmaceuticals: Strong Ojemda Launch Exceeds Expectations, Analyst Reiterates Overweight Rating

TipRanksNov 4 07:40 ET

A Quick Look at Today's Ratings for Day One Biopharmaceuticals(DAWN.US), With a Forecast Between $28 to $40

Moomoo NewsOct 31 09:19 ET

HC Wainwright & Co. Reiterates Buy on Day One Biopharmaceutical, Maintains $40 Price Target

BenzingaOct 31 07:29 ET

Day One Biopharm Price Target Maintained With a $33.00/Share by Needham

Dow JonesOct 31 06:51 ET

Day One Biopharmaceutical Analyst Ratings

BenzingaOct 31 06:41 ET

Piper Sandler Maintains Day One Biopharmaceuticals(DAWN.US) With Buy Rating, Maintains Target Price $40

Moomoo NewsOct 23 08:35 ET

3 Best Stocks to Buy Now, 10/9/2024, According to Top Analysts

TipRanksOct 9 07:24 ET

Day One Biopharmaceutical Analyst Ratings

BenzingaOct 9 05:43 ET

Needham Maintains Day One Biopharmaceuticals(DAWN.US) With Buy Rating, Raises Target Price to $33

Moomoo NewsOct 9 05:33 ET

Analysts Offer Insights on Healthcare Companies: Day One Biopharmaceuticals (DAWN) and Inari Medical (NARI)

TipRanksOct 9 05:32 ET

TD Cowen Maintains Day One Biopharmaceuticals(DAWN.US) With Buy Rating

Moomoo NewsSep 9 07:31 ET

TD Cowen Keeps Their Buy Rating on Day One Biopharmaceuticals (DAWN)

TipRanksSep 9 07:19 ET

Day One Biopharmaceutical Analyst Ratings

BenzingaAug 6 12:18 ET

BofA Securities Upgrades Day One Biopharmaceuticals(DAWN.US) to Buy Rating, Raises Target Price to $24

Moomoo NewsAug 1 06:31 ET

Day One Biopharmaceutical Analyst Ratings

BenzingaAug 1 06:27 ET

Oppenheimer Maintains Day One Biopharmaceuticals(DAWN.US) With Hold Rating

Moomoo NewsJul 31 15:32 ET

A Quick Look at Today's Ratings for Day One Biopharmaceuticals(DAWN.US), With a Forecast Between $32 to $40

Moomoo NewsJul 31 09:15 ET

Analysts Offer Insights on Healthcare Companies: Tilray (TLRY), Day One Biopharmaceuticals (DAWN) and Incyte (INCY)

TipRanksJul 31 08:37 ET

Piper Sandler Remains a Buy on Day One Biopharmaceuticals (DAWN)

TipRanksJul 31 06:58 ET